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ABSTRAK
Seorang pria usia 46 tahun, dari ICU dengan diagnosis saat masuk Guillain-Barre syndrome (GBS) + sepsis 
ec suspek ventilator associated pneumoniae (VAP), dimintakan bahan pemeriksaan laboratorium: darah lengkap, 
kultur, resistensi ujung selang suction, urinalisis dan kultur urin, kultur darah dan resistensi, procalcitonin dan 
laktat. Didapatkan neutrofilia, peningkatan procalcitonin dan laktat sesuai diagnosis sepsis, dan pada hasil kultur 
selang suction didapatkan kuman Pseudomonas luteola MDRO yang kemungkinan berasal dari kolonisasi pada 
oropharynx pasien, akibat higiene oral pasien yang buruk dan tindakan perawatan higiene oral oleh perawat 
yang kurang efektif, sehingga kuman yang berkolonisasi tersebut terbawa saat pengambilan sampel. Perawatan 
higiene oral yang tidak efektif potensial untuk terjadinya VAP dan VAP berulang. 
Kata kunci: ventilator associated pneumonia (VAP), Guillain-Barre syndrome (GBS), alur gyssen, higiene 
oral.
ABSTRACT
A 46-year-old man was admitted to ICU with a diagnosis at the time of admission of Guillain Barre Syndrome 
(GBS) and sepsis due to suspected Ventilator-Associated Pneumoniae (VAP). Specimens for the following 
laboratory workup were inquired, i.e. complete blood count, culture and resistance workup using specimens 
obtained from the tip of suction pipe, urinalysis and urine culture, blood culture and resistance, procalcitonin and 
lactate levels. Neutrophilia was found along with increased procalcitonin and lactate levels, which supported the 
sepsis diagnosis. Moreover, the result of culture from suction pipe demonstrated colonies of Pseudomonas luteola 
MDRO, which might be originated from the oropharyngeal colonization of the patients due to poor oral hygiene 
and ineffective oral hygiene nursing; therefore, the colonies of the microorganism were swabbed away when 
obtaining the specimens. Ineffective oral hygiene nursing may have a potency to cause VAP and recurrent VAP. 
Keywords: ventilator associated pneumonia (VAP), Guillain-Barre syndrome (GBS), Gyssen algorithm, 
oral hygiene.
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INTRODUCTION
Ventilator-associated pneumonia (VAP) is a 
pneumonia that occurs 48 hours or longer after 
mechanical ventilation or following endotracheal 
intubation.1,2 It is the most common Healthcare 
Associated Infections (HAIs) in the Intensive 
Care Unit (ICU).3,4 Risk factors for VAP include 
chronic obstructive pulmonary disease, abnormal 
cough reflex, neuromuscular diseases that may 
put the patients at risk of respiratory failure 
and may require mechanical ventilation using 
ventilator.1,2,5 Healthcare personnel may have a 
role in VAP due to ineffective hand washing, poor 
oral hygiene, letting patients in supine position 
that may facilitate the occurrence of aspiration 
and invasive procedures such as installation of 
nasogastric tube (NGT) and ventilator.5 The 
duration of installed intubation should be no 
more than 7 days and if the intubation is still 
necessary, it should be replaced with a new one.6-8
CASE ILLUSTRATION
Mr. M, a 46-year-old man came to the 
Emergency Department with a complaint of 
hands and feet paralysis and breathing difficulty. 
Since the last 2 weeks, he felt weakness of both 
legs so that he could not walk and along with 
time, he also experienced weakness of his both 
arms, which caused him unable to raise his hand 
and subsequently, he felt difficulty in breathing. 
He was admitted for further care. He had an 
intravenous line and had received neurological 
medications, but had no improvement, the patient 
asked for a referral.
On physical examination, the patient was 
fully alert with blood pressure of 135/80 mmHg, 
pulse rate of 80 beats per minute, respiratory 
rate of 30 times per minute and a temperature 
of  360C. Poor oral hygiene, tetraparesis and 
motor strength grade 1 were found. There was 
no abnormality in sensory function. Pathological 
reflex was not found. Chest X-ray revealed 
that the heart and lung were within normal 
limit. A diagnosis of Guillain-Barre Syndrome 
(GBS) with a threat of respiratory failure was 
established. The patient received treatment 
of intravenous fluid drip (IVFD) of Ringer 
Lactate (RL) at the dose of 10 drips/minute and 
Gammaras (an intravenous immunoglobulin) at 
the dose of 0.5 ml/kgBW/day. At the Emergency 
Department, the patient had the following 
laboratory workup including complete blood 
count, urinalysis, blood chemistry test and blood 
gas analysis and then he was hospitalized in the 
ICU. Results of complete blood count revealed 
neutrophilia; while the urinalysis showed data 
of normal limit. The results of blood chemistry 
test demonstrated normal ALT, AST, total 
protein, albumin, globulin and blood glucose 
levels. Ureum and creatinine levels were within 
normal limits. The blood gas analysis showed 
an impression of acidosis with normal anion 
gap (Table 1).
Table 1. Results of laboratory workup
Variables Value
Blood electrolytes
 - Sodium (mEq/L) 135
 - Potassium (mEq/L) 3.8
 - Chloride (mEq/L) (Normal anion gap) 106
Blood gas analysis
 - pH 7.350
 - pCO2 (mmHg) 55
 - pO2 (mmHg) 84.9
 - HCO3- (mmol/L) 32
 - O2 Saturated (%) 95.9
 - Base Excess (BE) (mmol/L) -0.9
 - Total CO2 (mmol/L) 25.6
The results of complete blood count at the 
ICU showed that there was a neutrophilia with a 
count of 16,000uL (normal range: 5000–10,000/
uL). Peripheral blood smear showed normocytic 
normochromic result and neutrophilia with toxic 
granulation and vacuolization. The reticulocyte 
count was 1.1% (normal range: 0.5–1.5%). 
Repeated chest X-ray showed a description of 
pneumonia on the left lung. The blood culture 
gave negative result. The resistance and culture 
test of the suction pipe tip showed results of 
Pseudomonas putida microorganism (Table 2).
The patient was then treated with ceftazidime 
at the dose of 3 x 1 gram/day dan Gammaras at 
the dose of 0.5 mL/kg BW/day. Five days later, 
the chest X-ray was repeated and a description of 
improved pneumonia was found; treatment using 
ceftazidime antibiotic was then stopped. Three 
days later, the patient seemed having short of 
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breath, leukocytosis and increasing neutrophila 
at 26,3 x103/uL (5.0–10.0) 103/uL. Results of 
blood gas analysis showed a combination of 
respiratory and metabolic acidosis along with 
increased anion gap (Table 3).
The microbiology culture test of the suction 
pipe tip was repeated and we found a result of 
Pseudomonas luteola MDRO; however, the 
possibility of contamination during obtaining 
the specimens due to colonization still could be 
excluded (Table 4).
DISCUSSION
A patient with a complaint of breathing 
difficulty and tetraparesis since approximately 
2 weeks before hospitalized. He was diagnosed 
with Guillain Barre Syndrome with a threat of 
respiratory failure. Guillain-Barre syndrome 
is a rare autoimmune disease in the form of 
polyneuropathy due to demyelination of nerve 
fibers with characteristics of symmetrical 
and progressive ascending muscle weakness, 
paralysis and hyporeflexia, with or without 
sensory or autonomic symptoms. The muscle 
weakness causes respiratory failure and medical 
emergency that requires immediate care. The 
blood gas analysis results indicated a respiratory 
acidosis due to neuromuscular disease (GBS) 
causing abnormal chest wall motion and 
respiratory depression since there was abnormal 
CO2 expiration, CO2 accumulation and those 
resulting in respiratory acidosis and a threat of 
respiratory failure.9,10
The patient was then admitted to the ICU and 
a ventilator was installed. Two days following 
the ventilator installation in the ICU, the patient 
had a fever (37.80C), severe leukocytosis and his 
chest X-ray revealed a description of pneumonia 
in his lower left lung and a diagnosis of sepsis due 
to VAP (early onset VAP) was established since it 
was developed during the first 4 days following 
an intubation or a ventilator installation. Based 
on the onset of infection, VAP is categorized 
into 2 groups, i.e. the early-onset VAP, which 
the VAP occurs within the first 4 days following 
an intubation and a ventilator installation; while 
the late-onset VAP is VAP that occurs more than 
5 days after a ventilator installation. About 50% 
of VAP cases occur in the first 4 days following 
a ventilator installation (early-onset VAP), which 
Table 2. Results of culture and resistance test of the 
suction pipe tip




acid S Amikacin S
Ampicillin sulbactam R Gentamicin S
Cefuroxime R Ciprofloxacin S
Ceftazidime S Levofloxacin S
Cefotaxime R Cotrimoxazole S
Ceftriaxone S Chloramphenicol S
Cefepime S Fosfomycin S
Meropenem S






O2 Saturasi (%) 95.7
Base Excess (BE) 
(mmol/L)
-8.9




Anion Gap: 22.65  (increased); Impression: respiratory + 
metabolic acidosis
Table 4. Results of culture and resistance test of the 
suction pipe tip




acid R Amikacin R
Ampicillin sulbactam R Gentamicin R
Cefuroxime R Ciprofloxacin R
Ceftazidime R Levofloxacin R
Cefotaxime R Cotrimoxazole S
Ceftriaxone R Chloramphenicol R
Cefepime R Fosfomycin R
Meropenem S
Procalcitonin level (semiquantitative test):  ≥0.5 - <2 ng/
mL; lactate level of 6.2 mmol/L
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usually has a good prognosis and caused by 
bacteria that are still sensitive to many antibiotic 
treatment. On the contrary, late-onset VAP is 
caused by multidrug-resistant organism (MDRO) 
to antibiotics, which is usually due to excessive 
exposure to antibiotics or irrational antibiotic 
treatment and it has been associated with higher 
morbidity and mortality rate compared to the 
early-onset VAP.1,5,6
Furthermore, urinalysis, urine culture, blood 
culture and culture of the suction pipe tip were 
estimated. Results of urinalysis showed no 
abnormality and urine culture demonstrated no 
growth and blood culture also gave negative 
results, but the results of suction pipe tip culture 
revealed Pseudomonas putida, which was only 
resistant to ampicillin sulbactam, cefotaxime 
and cefuroxime.
Ventilator-associated pneumonia is usually 
caused by negative-Gram bacteria, either single 
or polymicrobial infection or by positive-Gram 
bacteria as well. In immunocompromised 
patients, although it is a rare occasion, VAP 
may be caused by fungi such as Candida sp or 
Aspergillus sp. The negative-Gram bacteria that 
commonly serve as the etiology are Escherichia 
coli, Klebsiella pneumoniae, Pseudomonas 
sp (mostly P aeruginosa) and Acinetobacter 
sp; while the positive-Gram bacteria such as 
Staphylococcus aureus or Streptococcus sp 
may also be the cause of VAP.1,2,6 El Sohl1 as 
quoted from the American Thoracic Society, 
has found data that the causal bacteria of 
late-onset VAP are S. aureus (29%), negative-
Gram rod (15%), S. pneumoniae (9%) and 
Pseudomonas sp (4%). MDRO pathogens are 
mostly found in patients with late-onset VAP 
or those with immunocompromised condition.1 
Other Pseudomonas sp. such as P putida and P 
luteola are microorganisms that very much live 
in moist environment and places. They rarely 
infect humans, but may contaminate water and 
cause HAIs; however, they are not the causal 
microorganism of VAP.2 Considering the less 
common type of microorganism found in the 
cases, the possibility of contamination during 
obtaining specimens due to colonization still 
cannot be ruled out and good oral hygiene 
care is recommended for the patient to prevent 
microorganism colonization along with providing 
education for the ICU nurses on how to obtain 
correct and appropriate specimens as well as 
repeated specimen collection.
In the Guillain-Barre syndrome, abnormal 
cough reflex may occur4,5 and patients may 
have difficulties in expectorating sputum; 
moreover, the oral hygiene of the patient is 
also poorly maintained. Pseudomonas putida, 
which was found in the culture is probably an 
environmental microorganism that had been 
colonized in the oral cavity and oropharynx of 
the patient and it was taken during collecting 
the sample from the suction pipe in the ICU. 
Collecting specimen from difficult sputum 
expectoration and considering that the specimen 
could be presented by a piece cut of suction pipe 
is actually not recommended as there is a huge 
possibility of contamination of colonization due 
to sample collection. However, when we look at 
the pathogenesis of VAP, P. putida  may still be 
considered as the cause of VAP, which initially 
formed a colonization in the oropharynx and 
then it was inhaled during ventilator installation 
and it is assumed causing lung infection (VAP) 
although it is a less common microorganism for 
causing VAP and rarely cause infection in human. 
Moreover, until now, there is no literature that 
suggests P. putida as the cause of VAP. To confirm 
it, repeated sampling should be done at that time 
using the correct and appropriate technique of 
collecting specimens.
Without waiting for culture results, the patient 
was given empiric treatment, i.e. 5-day course 
of ceftazidime and he had improvement with 
normal description of chest X-ray. An evaluation 
using Gyssen algorithm for ceftazidime treatment 
without waiting for the results of culture in 
the patient (empiric treatment) was found 
in his complete medical record, which also 
include appropriate indication, narrow-spectrum 
antibiotic, non-expensive, safe and most effective 
treatment as well as appropriate duration, dose, 
interval and route of administration; therefore, 
the evaluation using Gyssen algorithm for 
empiric treatment of ceftazidime was seized at 
the number of zero, i.e. it was included as correct 
and appropriate category (Figure 1).
Three days later, the patient had another 
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fever (380C), neutrophilia and his chest X-ray 
revealed pneumonia on his upper right lung, he 
had purulent sputum, elevated procalcitonin and 
lactate levels and the blood glass analysis showed 
a description of respiratory and metabolic 
acidosis with increased anion gap. Increased 
anion gap in this case occurred due to increased 
lactate levels. Elevated HCO3- that may occur 
to compensate respiratory acidosis resulting 
from increased CO2 levels in the blood (due 
to respiratory failure), had actually never been 
achieved.
It may happen since there was metabolic 
acidosis due to increased lactate levels and 
therefore, the HCO3- concentration was reduced 
with decreased base excess. Consequently, 
a condition of combined respiratory and 
metabolic acidosis took place. Based on results 
of physical examination and laboratory data, a 
diagnosis of sepsis caused by VAP was made, 
which was supported by the laboratory result of 
procalcitonin of >0.5-<2 ng/mL, which was in 
accordance with the sepsis category. Moreover, 
there was also increased lactate levels (6.2 
mmol/L), which was appropriate to the tissue 
hypo-perfusion that may be found in sepsis. 
Based on those clinical and laboratory data, a 
diagnosis of Guillain Barre Syndrome (GBS) 
+ sepsis due to suspected Ventilator Associated 
Pneumonia (VAP) was established. An evaluation 
of culture and resistance test of the suction pipe 
tip was repeated including blood culture and 
resistance as well as urinalysis and urine culture 
and procalcitonin and lactate levels. It revealed 
a normal result of urinalysis, negative result of 
urine culture and negative result of blood culture. 
The culture of suction pipe tip showed a result 
of MDRO Pseudomonas luteola, which was 
still sensitive to cotrimoxazole and meropenem. 
The microorganism may probably derive from 
colonization of the patient’s oropharynx that was 
taken during sample collection from the suction 
pipe tip by nurse. However, it is also possible 
that P. luteola was the causal microorganism of 
VAP that had been originally colonized in the 
patient’s oropharynx, which was then inhaled 
during ventilator installation and infected the 
lung. Subsequently, VAP may occur although 
until now P. luteola is rarely found cause direct 
infection in human and there is no data about P. 
luteola as the cause of VAP.
The intubation itself would suppress cough 
reflex that has a function as protection against 
incoming pathogens. It also suppressed reflex of 
the epiglottis and therefore disturbing secretion 
clearance surrounding endotracheal tube (ETT). 
Therefore, when the pathogens have successfully 

























































Figure 1.  Gyssen algorithm for evaluating ceftazidime (empiric treatment)
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colonization in the area. Aspiration of pathogens 
that have been colonized in oropharynx or the 
insertion of secretion containing microorganism 
from the surroundings of installed ETT, is 
the main entrance for microorganism into the 
trachea.5
Continuous aspiration of subglottis secretion 
will reduce the risk of microorganism invasion to 
the trachea.8 DeRiso as quoted by the American 
Throacic Society4 suggested that oropharyngeal 
colonization, particularly by negative-Gram 
bacteria such as Pseudomonas aeruginosa, 
which occurs before hospital admission or 
which is acquired during hospitalization in the 
ICU are factors that have important roles in 
the development of VAP. Moreover, VAP may 
also occur by colonization of pathogens in the 
ventilator circuit system such as humidifier and 
suction. Colonization in the ETT or in ventilator 
circuit may also have the potency as a reservoir 
which contribute to the development of VAP.1,5 
Supine position facilitates the occurrence of 
aspiration compared to semi-recumbent or half-
sitting position (30-450); therefore, the patient 
should be maintained at semi-recumbent position 
to prevent aspiration.1,2,11
A closed suctioning system may also reduce 
the risk of VAP, but it is costly and has not 
been used widely.6,8 An immunocompromised 
condition or underlying disease related to 
respiratory disorder, colonization on the 
intubation pathway (oropharynx) prior to 
intubation, installation of invasive contaminated 
equipment and the presence of secretion retention 
in the contaminated subglottis area have a great 
role on the risk of developing VAP. A procedure 
of continuous aspiration of subglottis secretion 
can reduce the risk for developing VAP.1,2,5 In 
the ICU, a close-system ventilator has been used 
and a 450-HOB position has been performed; 
however, a contamination when obtaining 
sample due to colonization may still occur 
considering the poor oral hygiene of the patient. 
Oral hygiene care was not effectively performed 
by the nurse. Moreover, one of ventilator 
bundles, i.e. continuous suction of subglottis 
secretion was actually and technically difficult 
for the healthcare personnel and the maximum 
attempts were not performed; therefore, there is a 
possibility of microorganism colonization in the 
secretion concentrating in the subglottis area. The 
colonization of microorganisms has the potency 
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Figure 2. Gyssen algorithm for evaluating meropenem (definitive) based on results of culture test
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The patient was then treated in accordance 
with the results of culture and resistance test, i.e. 
receiving meropenem and had an improvement. 
The evaluation using the Gyssen algorithm can 
be considered from 2 points of view, which is 
when the treatment of meropenem as a definitive 
therapy based on the issued results of culture 
and resistance, then the definitive therapy of 
meropenem in this case is not appropriate 
to the indication, which was therapy against 
colonization; therefore, on the evaluation using 
Gyssen algorithm, the meropenem therapy stops 
at the number V (Figure 2). Nevertheless, if P. 
luteola is actually considered as the cause of 
VAP, then the evaluation of meropenem as the 
definitive treatment, we found a complete data 
of medical records, an appropriate indication, 
narrow-spectrum, less expensive, safe and most 
effective antibiotic with appropriate duration, 
dose, interval, route of administration and timing 
and the evaluation using Gyssen algorithm for 
meropenem therapy stops at the number zero, 
i.e. it is included in the correct and appropriate 
category. To confirm this issue, repeated culture 
specimen collection before antibiotic treatment 
should be performed along with a correct and 
appropriate procedure, which in this case had 
not been done.
CONCLUSION
Ineffective oral hygiene care has the potency 
of developing VAP and recurrent VAP. Obtaining 
samples must be performed using an appropriate 
procedure and if necessary, it must be repeated 
to have an accurate result. The interpretation 
of culture results must also be meticulously 
evaluated in order to provide useful information 
and effective for its management and treatment. 
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